CD274 and lymphoma: For example, inhibition of miR-155 expression can suppress the development of lymphoma [43], the upregulation of miR-425 can attenuate necroptosis and improve locomotor function [44], and inhibition of miR-34a can inhibit glioma progression and chemoresistance via targeting PD-L1 [45].